MedPath

BioNTech RNA Pharmaceuticals GmbH

🇩🇪Germany
Ownership
Subsidiary
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:1
Completed:2

Trial Phases

1 Phases

Phase 1:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 1
3 (100.0%)

IVAC MUTANOME Phase I Clinical Trial

Phase 1
Completed
Conditions
Melanoma
First Posted Date
2014-01-14
Last Posted Date
2020-01-18
Lead Sponsor
BioNTech RNA Pharmaceuticals GmbH
Target Recruit Count
15
Registration Number
NCT02035956
Locations
🇦🇹

Medizinische Universität Wien, Wien, AT-Wien, Austria

🇩🇪

Hautklinik und Poliklinik Universitätsmedizin der Johannes-Gutenberg Universität Mainz, Mainz, Germany

🇩🇪

Klinik für Dermatologie, Venerologie und Allergologie UMM - Universitätsmedizin Mannheim Medizinische Fakultät Mannheim der Ruprecht-Karls-Universität Heidelberg, Mannheim, Germany

RBL001/RBL002 Phase I Clinical Trial

Phase 1
Completed
Conditions
Melanoma
First Posted Date
2012-09-12
Last Posted Date
2020-01-18
Lead Sponsor
BioNTech RNA Pharmaceuticals GmbH
Target Recruit Count
29
Registration Number
NCT01684241
Locations
🇦🇹

Medizinische Universität Wien, Abteilung für Dermatologie, Vienna, Austria

🇩🇪

Medizinische Fakultät der Universität Duisburg-Essen, Essen, Germany

🇩🇪

Universtitätsmedizin der Johannes-Gutenberg Universtität, Mainz, Germany

and more 1 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.